Clinical trial
FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
NCT00370097 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00370097 |
|---|---|
| Title | FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects |
| Official title | PD of Hydrofluoroalkane Propellant of Inhaled Fluticasone Propionate Following Administration in Pediatric Subjects 6-12 Months of Age With Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | FLOVENT (fluticasone propionate) HFA, Placebo HFA |
| Enrollment | 16 |
| Start date | Aug 30, 2006 |
| Primary completion | Apr 12, 2007 |
| Completion | Apr 12, 2007 |
| First posted | Aug 30, 2006 |
| Last update posted | Sep 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: